A goal of the VCU Parkinson’s and Movement Disorders Center is to advance the understanding of Parkinson’s and related conditions, in terms of defining biological causes and developing novel treatments. Ongoing clinical research is necessary to achieve this important goal. A unique feature of this center is the on-site collaboration of clinician specialists representing several disciplines that bring a diverse knowledge and perspective to clinical research investigations.
The center relies on volunteers to partner with us to achieve these goals and advance the understanding of movement disorders. By participating in clinical research, individuals have the opportunity to contribute to the discovery of new medications and therapies to treat movement disorders.
Types of clinical research
The VCU Parkinson's and Movement Disorders Center conducts both observational and interventional research projects.
- Observational: Extracting and analyzing information from both clinical care and specific clinical research evaluations, obtaining and analyzing specimens such as blood or spinal fluid
- Interventional: Testing of a novel cognitive or exercise treatment, or a trial of an experimental drug or device
Participation in research projects is always voluntary, can be stopped at any time, and will not affect client access to the Parkinson’s and Movement Disorders Center evaluation or treatment process.
Learn more about volunteering
Choosing to participate in a clinical research project is an important personal decision. It is important to understand how clinical research projects are structured and what to expect as a participant before enrolling. The VCU Clinical Trials office provides information for potential research volunteers, including glossary of commonly used terms in clinical trials, and your questions answered.
Current VCU Parkinson's and Movement Disorders Center clinical research projects
- Essential Tremor
- Huntington Disease
- Parkinson's Disease
- Parkinson's Disease
- Computer-Based Cognitive Training for Individuals with Parkinson’s Disease
- Erythromycin in Parkinson's Disease
- Lifestyle Factors and Cognition in older adults
- Mindfulness-Based Stress Reduction for Individuals with Parkinson's Disease and their Caregivers
- Neurocognitive Intervention and Supportive Therapy in Individuals with Parkinson’s Disease and Their Support Persons